BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6644423)

  • 1. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification.
    Bowyer SL; Blane CE; Sullivan DB; Cassidy JT
    J Pediatr; 1983 Dec; 103(6):882-8. PubMed ID: 6644423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
    Fisler RE; Liang MG; Fuhlbrigge RC; Yalcindag A; Sundel RP
    J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculitis and calcinosis in juvenile dermatomyositis.
    Truckenbrodt H; Häfner R
    Acta Univ Carol Med (Praha); 1991; 37(1-2):8-15. PubMed ID: 1845413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcinosis of childhood dermatomyositis. Apropos of 10 cases].
    Bruguier A; Texier P; Sluzewski W; Ponsot G; Arthuis M
    Helv Paediatr Acta; 1984 Mar; 39(1):47-54. PubMed ID: 6724996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis.
    Ostrov BE; Goldsmith DP; Eichenfield AH; Athreya BH
    J Rheumatol; 1991 Nov; 18(11):1730-4. PubMed ID: 1787495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-center analysis of calcinosis in children with juvenile dermatomyositis].
    Miyamae T; Mori M; Inamo Y; Kohno Y; Takei S; Maeda M; Murata T; Nakata S; Kawai H; Hirano Y; Date Y; Kitamura K; Yokota S
    Ryumachi; 2003 Jun; 43(3):538-43. PubMed ID: 12910962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis.
    Oliveri MB; Palermo R; Mautalen C; Hübscher O
    J Rheumatol; 1996 Dec; 23(12):2152-5. PubMed ID: 8970055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
    Wang A; Morgan GA; Paller AS; Pachman LM
    J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem.
    Ichiki Y; Akiyama T; Shimozawa N; Suzuki Y; Kondo N; Kitajima Y
    Br J Dermatol; 2001 Apr; 144(4):894-7. PubMed ID: 11298557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatomyositis in the pediatric patient.
    Sullivan DB; Cassidy JT; Petty RE
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):327-31. PubMed ID: 263908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
    Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
    Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcinosis as the presenting sign of juvenile dermatomyositis in a 14-month-old boy.
    Martini A; Ravelli A; Viola S; Sambugaro R; De Benedetti F
    Helv Paediatr Acta; 1987 Oct; 42(2-3):181-4. PubMed ID: 3692883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
    Tayfur AC; Topaloglu R; Gulhan B; Bilginer Y
    Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK; Yang YH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT assessment of calcinosis in a patient with dermatomyositis.
    Fishel B; Diamant S; Papo I; Yaron M
    Clin Rheumatol; 1986 Jun; 5(2):242-4. PubMed ID: 3731719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
    Hoeltzel MF; Oberle EJ; Robinson AB; Agarwal A; Rider LG
    Curr Rheumatol Rep; 2014 Dec; 16(12):467. PubMed ID: 25366934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood dermatomyositis. Clinical course and long-term follow-up.
    Miller LC; Michael AF; Kim Y
    Clin Pediatr (Phila); 1987 Nov; 26(11):561-6. PubMed ID: 3665326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.
    Marco Puche A; Calvo Penades I; Lopez Montesinos B
    Clin Exp Rheumatol; 2010; 28(1):135-40. PubMed ID: 20346254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcinosis universalis in dermatomyositis].
    Garbsch H; Radl H
    Fortschr Geb Rontgenstr Nuklearmed; 1969 Nov; 111(5):697-703. PubMed ID: 4243864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.